MedPath
HSA Approval

CEFAZOLIN ALVOGEN POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/VIAL

SIN14846P

CEFAZOLIN ALVOGEN POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/VIAL

CEFAZOLIN ALVOGEN POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/VIAL

September 16, 2015

LOTUS INTERNATIONAL PTE. LTD.

LOTUS INTERNATIONAL PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantLOTUS INTERNATIONAL PTE. LTD.
Licence HolderLOTUS INTERNATIONAL PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

**4.2 Posology and method of administration** Posology _Recommended dosage for intravenous administration_ The following doses can be adjusted depending on the severity of the infection: ![Cefazolin Alvogen Dosage Table 1](https://cdn.medpath.com/drug/dosage/20240520/ecdcedf618230a4fb5968e028d171638.png) The safety of cefazolin in pre-term newborns and neonates has not been established. Therefore, the use of cefazolin is not recommended. _Recommended dosage for intramuscular administration_ The following doses can be adjusted depending on the severity of the infection: ![Cefazolin Alvogen Dosage Table 2](https://cdn.medpath.com/drug/dosage/20240520/a2b5642fbc3dc8b9de18b087ebdaae4c.png) _Recommended dosage in patients with renal impairment_ Severe infections: ![Cefazolin Alvogen Dosage Table 3](https://cdn.medpath.com/drug/dosage/20240520/86878620f7534e9bc405708a99dfb32d.png) Mild infections: ![Cefazolin Alvogen Dosage Table 4](https://cdn.medpath.com/drug/dosage/20240520/84a804a3e5e69a1ccb8907186d31616d.png) _Prophylaxis of post-operative infections_ Generally, the prophylactic administration of the medicinal product should be short-term – within 24 to 48 hours. - The usual dose is 1 g intravenously administered during the induction of anaesthesia, followed by a dose of 0.5–1 g administered intravenously every 6–8 hours for 24 hours postoperatively. - For operative procedures lasting longer than 2 hours, 0.5–1 g is administered intravenously during surgery. Method of administration CEFAZOLIN ALVOGEN is administered by deep intramuscular injection or by intravenous bolus injection or infusion. The powder for solution for injection or infusion should be initially diluted with 2–3 ml of diluent. The solution should be further reconstituted as follows: _Intramuscular injection:_ The solution is further reconstituted with water for injection (concentration of the solution 250 mg/ml). _Intravenous injection:_ The solution is further reconstituted with water for injection (concentration of the solution 100 mg/ml). CEFAZOLIN ALVOGEN may be administered either by slow intravenous injection over a period of 3 to 5 min directly into a vein or _via_ a drip tube. _Intravenous infusion:_ The solution is further reconstituted with one of the following compatible diluents (concentration of the solution 20 mg/ml): - 0.9% NaCl Injection, - 5% Glucose Injection, - 10% Glucose Injection, - 5% Glucose and 0.9% NaCl Injection, - 5% Glucose and 0.45% NaCl Injection, - 5% Glucose and 0.225% NaCl Injection, - 4% Glucose and 0.18% NaCl Injection, - Compound sodium chloride injection, - Lactated Ringer’s injection. For instructions on reconstitution and dilution of the medicinal product before administration, see section 6.6 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.

INTRAVENOUS, INTRAMUSCULAR

Medical Information

**4.1 Therapeutic indications** CEFAZOLIN ALVOGEN is indicated in adults and children for the treatment of the following infections due to bacteria which are susceptible to cefazolin: - Respiratory tract infections. - Sepsis. - Skin and soft tissue infections. - Endocarditis. - Urinary tract and genital infections. - Bile duct infections. - Bone and joint infections. Other indications that require only intravenous administration: CEFAZOLIN ALVOGEN is indicated for pre-operative prophylaxis of post-operative infections in: - Neurosurgery (craniotomy, liquor derivation). - Cardiac surgery. - Thoracic surgery. - Vascular surgery. - Gastro-intestinal surgery. - Hepatobiliary surgery. - Caesarean section. - Abdominal or vaginal hysterectomy. - Surgery of the head and neck with oropharynx opening. - Orthopaedic surgery. Consideration should be given to official guidance on the appropriate use of antibiotics.

**4.3 Contraindications** Hypersensitivity to the active substance or any other cephalosporins. Pre-term newborns and neonates The safety of cefazolin in pre-term newborns and neonates has not been established. Therefore, the use of cefazolin is not recommended.

J01DB04

cefazolin

Manufacturer Information

LOTUS INTERNATIONAL PTE. LTD.

Sinopharm Zhijun (Shenzhen) Pharmaceutical Co., Ltd

Active Ingredients

Cefazolin Sodium 1.048g eqv to Cefazolin

1 g

Cefazolin

Documents

Package Inserts

Cefazolin Singapore 1g PI.pdf

Approved: September 11, 2020

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.